Expression profile and differential regulation of the Human I-mfa domain-Containing protein (HIC) gene in immune cells.
The Human I-mfa domain-Containing protein, HIC, is a 246 amino acid protein that functions as a transcriptional regulator. Although the precise function of HIC remains to be clarified, the association of the HIC gene locus with myeloid neoplasms, its interactions with lymphotropic viruses such as EBV, HIV-1 and HTLV-1 and its expression in immune tissues suggest that HIC might have a modulatory role in immune cells. To further characterise the HIC functional relationship with the immune system, we sought to analyse the HIC gene expression profile in immune cells and to determine if immunomodulatory cytokines, such as interleukin (IL)-2, could regulate the expression of HIC mRNA. Relative quantitative real-time RT-PCR revealed that HIC mRNA is highly expressed in PBMCs and in various hematopoietic cell lines. The immunomodulatory cytokine IL-2 up-regulated HIC gene expression in PBMCs, CEM, MT-2 and U937 but markedly reduced HIC gene expression in Raji. Addition of cycloheximide indicated that the IL-2 effects were independent of de novo protein synthesis and that the HIC gene is a direct target of IL-2. Two cell lines (Jurkat and BJAB) displayed a distinct loss in HIC gene expression. However, when these cell lines were subjected to a combination of DNA methyltransferase and histone-deacetylase inhibitors, (5-aza-2-deoxycytidine and trichostatin A, respectively), HIC expression was de-repressed, indicating possible epigenetic control of HIC expression. Overall, our study describes that the immune expression of HIC is cell-specific, dynamic, and identifies the HIC gene as an IL-2 responsive gene. Furthermore, our de-repression studies support the hypothesis that HIC might represent a candidate tumor suppressor gene. Overall, this report provides new insights for a putative role of HIC in the modulation of immune and inflammatory responses and/or hematological malignancies.
School of Medicine and Medical Science, Centre for Research in Infectious Diseases, University College Dublin, Belfield, Dublin 4, Ireland. lili.gu@ucd.ie
Lili
L
Gu
Jonathan
J
Dean
André L A
AL
Oliveira
Noreen
N
Sheehy
William W
WW
Hall
Virginie W
VW
Gautier
D001372:Aza Compounds / Q000494:pharmacology; D045744:Cell Line, Tumor; D044127:Epigenesis, Genetic / Q000187:drug effects; D020869:Gene Expression Profiling; D006367:HeLa Cells; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D007376:Interleukin-2 / Q000276:immunology*; D018006:Myogenic Regulatory Factors / Q000187:drug effects / Q000235:genetics*
D001372:Aza Compounds; D006877:Hydroxamic Acids; D007376:Interleukin-2; C478034:MDFIC protein, human; D018006:Myogenic Regulatory Factors